ACG
DNA.WS
Anchorage Capital Group’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50,000
| Closed | -$1.41K | – | 8 |
|
|
2024
Q2 | $1.41K | Hold |
50,000
| – | – | ﹤0.01% | 8 |
|
|
2024
Q1 | $4.5K | Hold |
50,000
| – | – | ﹤0.01% | 9 |
|
|
2023
Q4 | $5.27K | Hold |
50,000
| – | – | ﹤0.01% | 15 |
|
|
2023
Q3 | $11.3K | Hold |
50,000
| – | – | ﹤0.01% | 16 |
|
|
2023
Q2 | $13.1K | Hold |
50,000
| – | – | ﹤0.01% | 15 |
|
|
2023
Q1 | $9K | Hold |
50,000
| – | – | ﹤0.01% | 17 |
|
|
2022
Q4 | $10K | Hold |
50,000
| – | – | ﹤0.01% | 19 |
|
|
2022
Q3 | $36K | Hold |
50,000
| – | – | ﹤0.01% | 23 |
|
|
2022
Q2 | $27K | Hold |
50,000
| – | – | ﹤0.01% | 23 |
|
|
2022
Q1 | $44K | Hold |
50,000
| – | – | ﹤0.01% | 22 |
|
|
2021
Q4 | $112K | Hold |
50,000
| – | – | ﹤0.01% | 18 |
|
|
2021
Q3 | $170K | Buy |
+50,000
| New | +$170K | ﹤0.01% | 20 |
|